Despite FDA setback, psychedelic pioneer is unfazed about MDMA’s prospects
Washington Post
Rick Doblin has spent more than 30 years developing MDMA to win approval from the FDA, which rejected it earlier this month. “I’m not gonna go smoke pot and hang out on my couch for the next 20 years,” he said.
https://www.washingtonpost.com/business/2024/08/27/ecstasy-mdma-fda-pyschedelic-medicine/